nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Galantamine—Alzheimer's disease	0.466	1	CrCtD
Oxycodone—Ethylmorphine—Galantamine—Alzheimer's disease	0.0829	0.306	CrCrCtD
Oxycodone—CYP2D6—Alzheimer's disease	0.0803	1	CbGaD
Oxycodone—Codeine—Galantamine—Alzheimer's disease	0.0755	0.278	CrCrCtD
Oxycodone—Dihydrocodeine—Galantamine—Alzheimer's disease	0.06	0.221	CrCrCtD
Oxycodone—Hydrocodone—Galantamine—Alzheimer's disease	0.053	0.195	CrCrCtD
Oxycodone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0259	0.264	CbGbCtD
Oxycodone—CYP2D6—Donepezil—Alzheimer's disease	0.0207	0.211	CbGbCtD
Oxycodone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0164	0.168	CbGbCtD
Oxycodone—CYP2D6—Galantamine—Alzheimer's disease	0.0133	0.136	CbGbCtD
Oxycodone—CYP3A4—Donepezil—Alzheimer's disease	0.0131	0.134	CbGbCtD
Oxycodone—CYP3A4—Galantamine—Alzheimer's disease	0.00847	0.0865	CbGbCtD
Oxycodone—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00127	0.208	CbGeAlD
Oxycodone—OPRD1—forebrain—Alzheimer's disease	0.000488	0.0796	CbGeAlD
Oxycodone—OPRK1—forebrain—Alzheimer's disease	0.000467	0.0763	CbGeAlD
Oxycodone—OPRD1—telencephalon—Alzheimer's disease	0.000448	0.0732	CbGeAlD
Oxycodone—Naloxone—CREB1—Alzheimer's disease	0.000414	0.225	CrCbGaD
Oxycodone—OPRM1—forebrain—Alzheimer's disease	0.000332	0.0543	CbGeAlD
Oxycodone—OPRM1—telencephalon—Alzheimer's disease	0.000306	0.0499	CbGeAlD
Oxycodone—Galantamine—CHRNB2—Alzheimer's disease	0.000272	0.148	CrCbGaD
Oxycodone—OPRD1—nervous system—Alzheimer's disease	0.000265	0.0432	CbGeAlD
Oxycodone—OPRD1—central nervous system—Alzheimer's disease	0.000255	0.0416	CbGeAlD
Oxycodone—OPRK1—nervous system—Alzheimer's disease	0.000254	0.0414	CbGeAlD
Oxycodone—OPRK1—central nervous system—Alzheimer's disease	0.000244	0.0399	CbGeAlD
Oxycodone—OPRK1—cerebellum—Alzheimer's disease	0.000239	0.039	CbGeAlD
Oxycodone—OPRD1—brain—Alzheimer's disease	0.000202	0.033	CbGeAlD
Oxycodone—OPRK1—brain—Alzheimer's disease	0.000194	0.0317	CbGeAlD
Oxycodone—OPRM1—nervous system—Alzheimer's disease	0.00018	0.0295	CbGeAlD
Oxycodone—OPRM1—central nervous system—Alzheimer's disease	0.000174	0.0284	CbGeAlD
Oxycodone—Galantamine—CHRNA7—Alzheimer's disease	0.000159	0.0867	CrCbGaD
Oxycodone—Galantamine—ACHE—Alzheimer's disease	0.000141	0.0765	CrCbGaD
Oxycodone—OPRM1—brain—Alzheimer's disease	0.000138	0.0225	CbGeAlD
Oxycodone—CYP2D6—forebrain—Alzheimer's disease	0.000133	0.0218	CbGeAlD
Oxycodone—Galantamine—CHRNA4—Alzheimer's disease	0.000127	0.0693	CrCbGaD
Oxycodone—CYP2D6—telencephalon—Alzheimer's disease	0.000123	0.02	CbGeAlD
Oxycodone—Methylnaltrexone—CYP2D6—Alzheimer's disease	8.8e-05	0.0479	CrCbGaD
Oxycodone—Galantamine—BCHE—Alzheimer's disease	8.27e-05	0.045	CrCbGaD
Oxycodone—Rhinitis—Memantine—Alzheimer's disease	8.21e-05	0.00122	CcSEcCtD
Oxycodone—Haemorrhage—Memantine—Alzheimer's disease	8.19e-05	0.00122	CcSEcCtD
Oxycodone—Hepatitis—Memantine—Alzheimer's disease	8.19e-05	0.00122	CcSEcCtD
Oxycodone—Bradycardia—Rivastigmine—Alzheimer's disease	8.16e-05	0.00121	CcSEcCtD
Oxycodone—Hypoaesthesia—Memantine—Alzheimer's disease	8.15e-05	0.00121	CcSEcCtD
Oxycodone—Hallucination—Memantine—Alzheimer's disease	8.15e-05	0.00121	CcSEcCtD
Oxycodone—Shock—Galantamine—Alzheimer's disease	8.14e-05	0.00121	CcSEcCtD
Oxycodone—Pharyngitis—Memantine—Alzheimer's disease	8.13e-05	0.00121	CcSEcCtD
Oxycodone—Nervous system disorder—Galantamine—Alzheimer's disease	8.11e-05	0.00121	CcSEcCtD
Oxycodone—Chills—Donepezil—Alzheimer's disease	8.1e-05	0.0012	CcSEcCtD
Oxycodone—Urinary tract disorder—Memantine—Alzheimer's disease	8.09e-05	0.0012	CcSEcCtD
Oxycodone—Tachycardia—Galantamine—Alzheimer's disease	8.07e-05	0.0012	CcSEcCtD
Oxycodone—Oedema peripheral—Memantine—Alzheimer's disease	8.07e-05	0.0012	CcSEcCtD
Oxycodone—Haemoglobin—Rivastigmine—Alzheimer's disease	8.06e-05	0.0012	CcSEcCtD
Oxycodone—Connective tissue disorder—Memantine—Alzheimer's disease	8.05e-05	0.0012	CcSEcCtD
Oxycodone—Naloxone—ESR1—Alzheimer's disease	8.05e-05	0.0438	CrCbGaD
Oxycodone—Rhinitis—Rivastigmine—Alzheimer's disease	8.03e-05	0.00119	CcSEcCtD
Oxycodone—Skin disorder—Galantamine—Alzheimer's disease	8.03e-05	0.00119	CcSEcCtD
Oxycodone—Urethral disorder—Memantine—Alzheimer's disease	8.03e-05	0.00119	CcSEcCtD
Oxycodone—Hepatitis—Rivastigmine—Alzheimer's disease	8.01e-05	0.00119	CcSEcCtD
Oxycodone—Haemorrhage—Rivastigmine—Alzheimer's disease	8.01e-05	0.00119	CcSEcCtD
Oxycodone—Hyperhidrosis—Galantamine—Alzheimer's disease	8e-05	0.00119	CcSEcCtD
Oxycodone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	7.97e-05	0.00119	CcSEcCtD
Oxycodone—Hallucination—Rivastigmine—Alzheimer's disease	7.97e-05	0.00119	CcSEcCtD
Oxycodone—Pharyngitis—Rivastigmine—Alzheimer's disease	7.95e-05	0.00118	CcSEcCtD
Oxycodone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	7.91e-05	0.00118	CcSEcCtD
Oxycodone—Mental disorder—Donepezil—Alzheimer's disease	7.9e-05	0.00118	CcSEcCtD
Oxycodone—Oedema peripheral—Rivastigmine—Alzheimer's disease	7.9e-05	0.00117	CcSEcCtD
Oxycodone—Visual impairment—Memantine—Alzheimer's disease	7.89e-05	0.00117	CcSEcCtD
Oxycodone—Anorexia—Galantamine—Alzheimer's disease	7.88e-05	0.00117	CcSEcCtD
Oxycodone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	7.88e-05	0.00117	CcSEcCtD
Oxycodone—Urethral disorder—Rivastigmine—Alzheimer's disease	7.86e-05	0.00117	CcSEcCtD
Oxycodone—Malnutrition—Donepezil—Alzheimer's disease	7.85e-05	0.00117	CcSEcCtD
Oxycodone—Flatulence—Donepezil—Alzheimer's disease	7.74e-05	0.00115	CcSEcCtD
Oxycodone—Hypotension—Galantamine—Alzheimer's disease	7.73e-05	0.00115	CcSEcCtD
Oxycodone—Visual impairment—Rivastigmine—Alzheimer's disease	7.72e-05	0.00115	CcSEcCtD
Oxycodone—Tension—Donepezil—Alzheimer's disease	7.71e-05	0.00115	CcSEcCtD
Oxycodone—Dysgeusia—Donepezil—Alzheimer's disease	7.69e-05	0.00114	CcSEcCtD
Oxycodone—Eye disorder—Memantine—Alzheimer's disease	7.66e-05	0.00114	CcSEcCtD
Oxycodone—Tinnitus—Memantine—Alzheimer's disease	7.64e-05	0.00114	CcSEcCtD
Oxycodone—Nervousness—Donepezil—Alzheimer's disease	7.63e-05	0.00113	CcSEcCtD
Oxycodone—Cardiac disorder—Memantine—Alzheimer's disease	7.6e-05	0.00113	CcSEcCtD
Oxycodone—Flushing—Memantine—Alzheimer's disease	7.6e-05	0.00113	CcSEcCtD
Oxycodone—Back pain—Donepezil—Alzheimer's disease	7.6e-05	0.00113	CcSEcCtD
Oxycodone—Muscle spasms—Donepezil—Alzheimer's disease	7.55e-05	0.00112	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	7.54e-05	0.00112	CcSEcCtD
Oxycodone—Eye disorder—Rivastigmine—Alzheimer's disease	7.49e-05	0.00111	CcSEcCtD
Oxycodone—Dihydrocodeine—CYP2D6—Alzheimer's disease	7.49e-05	0.0407	CrCbGaD
Oxycodone—Insomnia—Galantamine—Alzheimer's disease	7.48e-05	0.00111	CcSEcCtD
Oxycodone—Tinnitus—Rivastigmine—Alzheimer's disease	7.47e-05	0.00111	CcSEcCtD
Oxycodone—Cardiac disorder—Rivastigmine—Alzheimer's disease	7.44e-05	0.00111	CcSEcCtD
Oxycodone—Flushing—Rivastigmine—Alzheimer's disease	7.44e-05	0.00111	CcSEcCtD
Oxycodone—Angiopathy—Memantine—Alzheimer's disease	7.43e-05	0.00111	CcSEcCtD
Oxycodone—Paraesthesia—Galantamine—Alzheimer's disease	7.43e-05	0.0011	CcSEcCtD
Oxycodone—Immune system disorder—Memantine—Alzheimer's disease	7.4e-05	0.0011	CcSEcCtD
Oxycodone—Mediastinal disorder—Memantine—Alzheimer's disease	7.38e-05	0.0011	CcSEcCtD
Oxycodone—Tremor—Donepezil—Alzheimer's disease	7.36e-05	0.00109	CcSEcCtD
Oxycodone—CYP3A4—nervous system—Alzheimer's disease	7.35e-05	0.012	CbGeAlD
Oxycodone—Somnolence—Galantamine—Alzheimer's disease	7.35e-05	0.00109	CcSEcCtD
Oxycodone—Chills—Memantine—Alzheimer's disease	7.35e-05	0.00109	CcSEcCtD
Oxycodone—Ill-defined disorder—Donepezil—Alzheimer's disease	7.29e-05	0.00108	CcSEcCtD
Oxycodone—Dyspepsia—Galantamine—Alzheimer's disease	7.28e-05	0.00108	CcSEcCtD
Oxycodone—Angiopathy—Rivastigmine—Alzheimer's disease	7.27e-05	0.00108	CcSEcCtD
Oxycodone—Anaemia—Donepezil—Alzheimer's disease	7.26e-05	0.00108	CcSEcCtD
Oxycodone—CYP2D6—nervous system—Alzheimer's disease	7.24e-05	0.0118	CbGeAlD
Oxycodone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	7.22e-05	0.00107	CcSEcCtD
Oxycodone—Agitation—Donepezil—Alzheimer's disease	7.22e-05	0.00107	CcSEcCtD
Oxycodone—Chills—Rivastigmine—Alzheimer's disease	7.19e-05	0.00107	CcSEcCtD
Oxycodone—Decreased appetite—Galantamine—Alzheimer's disease	7.19e-05	0.00107	CcSEcCtD
Oxycodone—Mental disorder—Memantine—Alzheimer's disease	7.18e-05	0.00107	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	7.14e-05	0.00106	CcSEcCtD
Oxycodone—Malnutrition—Memantine—Alzheimer's disease	7.13e-05	0.00106	CcSEcCtD
Oxycodone—Fatigue—Galantamine—Alzheimer's disease	7.13e-05	0.00106	CcSEcCtD
Oxycodone—Malaise—Donepezil—Alzheimer's disease	7.08e-05	0.00105	CcSEcCtD
Oxycodone—CYP3A4—central nervous system—Alzheimer's disease	7.08e-05	0.0116	CbGeAlD
Oxycodone—Constipation—Galantamine—Alzheimer's disease	7.07e-05	0.00105	CcSEcCtD
Oxycodone—Vertigo—Donepezil—Alzheimer's disease	7.06e-05	0.00105	CcSEcCtD
Oxycodone—Syncope—Donepezil—Alzheimer's disease	7.04e-05	0.00105	CcSEcCtD
Oxycodone—Flatulence—Memantine—Alzheimer's disease	7.03e-05	0.00105	CcSEcCtD
Oxycodone—Mental disorder—Rivastigmine—Alzheimer's disease	7.02e-05	0.00104	CcSEcCtD
Oxycodone—Tension—Memantine—Alzheimer's disease	7e-05	0.00104	CcSEcCtD
Oxycodone—Hydromorphone—PTGS1—Alzheimer's disease	6.98e-05	0.038	CrCbGaD
Oxycodone—Dysgeusia—Memantine—Alzheimer's disease	6.98e-05	0.00104	CcSEcCtD
Oxycodone—Malnutrition—Rivastigmine—Alzheimer's disease	6.98e-05	0.00104	CcSEcCtD
Oxycodone—CYP2D6—central nervous system—Alzheimer's disease	6.97e-05	0.0114	CbGeAlD
Oxycodone—Nervousness—Memantine—Alzheimer's disease	6.93e-05	0.00103	CcSEcCtD
Oxycodone—Loss of consciousness—Donepezil—Alzheimer's disease	6.9e-05	0.00103	CcSEcCtD
Oxycodone—Back pain—Memantine—Alzheimer's disease	6.9e-05	0.00103	CcSEcCtD
Oxycodone—Flatulence—Rivastigmine—Alzheimer's disease	6.87e-05	0.00102	CcSEcCtD
Oxycodone—Cough—Donepezil—Alzheimer's disease	6.85e-05	0.00102	CcSEcCtD
Oxycodone—Tension—Rivastigmine—Alzheimer's disease	6.85e-05	0.00102	CcSEcCtD
Oxycodone—Dysgeusia—Rivastigmine—Alzheimer's disease	6.83e-05	0.00102	CcSEcCtD
Oxycodone—Feeling abnormal—Galantamine—Alzheimer's disease	6.82e-05	0.00101	CcSEcCtD
Oxycodone—CYP2D6—cerebellum—Alzheimer's disease	6.81e-05	0.0111	CbGeAlD
Oxycodone—Convulsion—Donepezil—Alzheimer's disease	6.81e-05	0.00101	CcSEcCtD
Oxycodone—Nervousness—Rivastigmine—Alzheimer's disease	6.78e-05	0.00101	CcSEcCtD
Oxycodone—Gastrointestinal pain—Galantamine—Alzheimer's disease	6.76e-05	0.00101	CcSEcCtD
Oxycodone—Back pain—Rivastigmine—Alzheimer's disease	6.75e-05	0.001	CcSEcCtD
Oxycodone—Muscle spasms—Rivastigmine—Alzheimer's disease	6.71e-05	0.000998	CcSEcCtD
Oxycodone—Arthralgia—Donepezil—Alzheimer's disease	6.69e-05	0.000995	CcSEcCtD
Oxycodone—Chest pain—Donepezil—Alzheimer's disease	6.69e-05	0.000995	CcSEcCtD
Oxycodone—Myalgia—Donepezil—Alzheimer's disease	6.69e-05	0.000995	CcSEcCtD
Oxycodone—Tremor—Memantine—Alzheimer's disease	6.68e-05	0.000994	CcSEcCtD
Oxycodone—Anxiety—Donepezil—Alzheimer's disease	6.66e-05	0.000991	CcSEcCtD
Oxycodone—Ill-defined disorder—Memantine—Alzheimer's disease	6.62e-05	0.000984	CcSEcCtD
Oxycodone—Discomfort—Donepezil—Alzheimer's disease	6.61e-05	0.000983	CcSEcCtD
Oxycodone—Anaemia—Memantine—Alzheimer's disease	6.59e-05	0.00098	CcSEcCtD
Oxycodone—Oxymorphone—CYP2D6—Alzheimer's disease	6.56e-05	0.0357	CrCbGaD
Oxycodone—Agitation—Memantine—Alzheimer's disease	6.55e-05	0.000975	CcSEcCtD
Oxycodone—Dry mouth—Donepezil—Alzheimer's disease	6.54e-05	0.000973	CcSEcCtD
Oxycodone—Body temperature increased—Galantamine—Alzheimer's disease	6.54e-05	0.000973	CcSEcCtD
Oxycodone—Abdominal pain—Galantamine—Alzheimer's disease	6.54e-05	0.000973	CcSEcCtD
Oxycodone—Tremor—Rivastigmine—Alzheimer's disease	6.54e-05	0.000972	CcSEcCtD
Oxycodone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	6.47e-05	0.000963	CcSEcCtD
Oxycodone—Confusional state—Donepezil—Alzheimer's disease	6.46e-05	0.000961	CcSEcCtD
Oxycodone—Anaemia—Rivastigmine—Alzheimer's disease	6.45e-05	0.000959	CcSEcCtD
Oxycodone—Malaise—Memantine—Alzheimer's disease	6.43e-05	0.000957	CcSEcCtD
Oxycodone—Agitation—Rivastigmine—Alzheimer's disease	6.41e-05	0.000954	CcSEcCtD
Oxycodone—Oedema—Donepezil—Alzheimer's disease	6.41e-05	0.000953	CcSEcCtD
Oxycodone—Vertigo—Memantine—Alzheimer's disease	6.41e-05	0.000953	CcSEcCtD
Oxycodone—Syncope—Memantine—Alzheimer's disease	6.4e-05	0.000951	CcSEcCtD
Oxycodone—Leukopenia—Memantine—Alzheimer's disease	6.38e-05	0.000949	CcSEcCtD
Oxycodone—Infection—Donepezil—Alzheimer's disease	6.37e-05	0.000947	CcSEcCtD
Oxycodone—Shock—Donepezil—Alzheimer's disease	6.31e-05	0.000938	CcSEcCtD
Oxycodone—Palpitations—Memantine—Alzheimer's disease	6.3e-05	0.000937	CcSEcCtD
Oxycodone—Malaise—Rivastigmine—Alzheimer's disease	6.29e-05	0.000936	CcSEcCtD
Oxycodone—Nervous system disorder—Donepezil—Alzheimer's disease	6.29e-05	0.000935	CcSEcCtD
Oxycodone—Ethylmorphine—CYP2D6—Alzheimer's disease	6.27e-05	0.0341	CrCbGaD
Oxycodone—Vertigo—Rivastigmine—Alzheimer's disease	6.27e-05	0.000932	CcSEcCtD
Oxycodone—Loss of consciousness—Memantine—Alzheimer's disease	6.27e-05	0.000932	CcSEcCtD
Oxycodone—Syncope—Rivastigmine—Alzheimer's disease	6.26e-05	0.000931	CcSEcCtD
Oxycodone—Cough—Memantine—Alzheimer's disease	6.22e-05	0.000926	CcSEcCtD
Oxycodone—Hyperhidrosis—Donepezil—Alzheimer's disease	6.2e-05	0.000922	CcSEcCtD
Oxycodone—Convulsion—Memantine—Alzheimer's disease	6.18e-05	0.000919	CcSEcCtD
Oxycodone—Palpitations—Rivastigmine—Alzheimer's disease	6.17e-05	0.000917	CcSEcCtD
Oxycodone—Loss of consciousness—Rivastigmine—Alzheimer's disease	6.13e-05	0.000912	CcSEcCtD
Oxycodone—Anorexia—Donepezil—Alzheimer's disease	6.11e-05	0.000909	CcSEcCtD
Oxycodone—Hypersensitivity—Galantamine—Alzheimer's disease	6.09e-05	0.000906	CcSEcCtD
Oxycodone—Cough—Rivastigmine—Alzheimer's disease	6.09e-05	0.000905	CcSEcCtD
Oxycodone—Myalgia—Memantine—Alzheimer's disease	6.07e-05	0.000903	CcSEcCtD
Oxycodone—Arthralgia—Memantine—Alzheimer's disease	6.07e-05	0.000903	CcSEcCtD
Oxycodone—Chest pain—Memantine—Alzheimer's disease	6.07e-05	0.000903	CcSEcCtD
Oxycodone—Anxiety—Memantine—Alzheimer's disease	6.05e-05	0.0009	CcSEcCtD
Oxycodone—Convulsion—Rivastigmine—Alzheimer's disease	6.04e-05	0.000899	CcSEcCtD
Oxycodone—Discomfort—Memantine—Alzheimer's disease	6e-05	0.000892	CcSEcCtD
Oxycodone—Hypotension—Donepezil—Alzheimer's disease	5.99e-05	0.000891	CcSEcCtD
Oxycodone—Arthralgia—Rivastigmine—Alzheimer's disease	5.94e-05	0.000883	CcSEcCtD
Oxycodone—Myalgia—Rivastigmine—Alzheimer's disease	5.94e-05	0.000883	CcSEcCtD
Oxycodone—Chest pain—Rivastigmine—Alzheimer's disease	5.94e-05	0.000883	CcSEcCtD
Oxycodone—Dry mouth—Memantine—Alzheimer's disease	5.94e-05	0.000883	CcSEcCtD
Oxycodone—Asthenia—Galantamine—Alzheimer's disease	5.93e-05	0.000883	CcSEcCtD
Oxycodone—Anxiety—Rivastigmine—Alzheimer's disease	5.92e-05	0.00088	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	5.9e-05	0.000877	CcSEcCtD
Oxycodone—Confusional state—Memantine—Alzheimer's disease	5.87e-05	0.000873	CcSEcCtD
Oxycodone—Discomfort—Rivastigmine—Alzheimer's disease	5.87e-05	0.000873	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	5.84e-05	0.000869	CcSEcCtD
Oxycodone—Oedema—Memantine—Alzheimer's disease	5.82e-05	0.000866	CcSEcCtD
Oxycodone—Dry mouth—Rivastigmine—Alzheimer's disease	5.81e-05	0.000864	CcSEcCtD
Oxycodone—Insomnia—Donepezil—Alzheimer's disease	5.8e-05	0.000862	CcSEcCtD
Oxycodone—Infection—Memantine—Alzheimer's disease	5.78e-05	0.00086	CcSEcCtD
Oxycodone—Paraesthesia—Donepezil—Alzheimer's disease	5.76e-05	0.000856	CcSEcCtD
Oxycodone—Confusional state—Rivastigmine—Alzheimer's disease	5.74e-05	0.000854	CcSEcCtD
Oxycodone—Hydrocodone—CYP2D6—Alzheimer's disease	5.74e-05	0.0312	CrCbGaD
Oxycodone—Shock—Memantine—Alzheimer's disease	5.73e-05	0.000852	CcSEcCtD
Oxycodone—Dyspnoea—Donepezil—Alzheimer's disease	5.71e-05	0.00085	CcSEcCtD
Oxycodone—Nervous system disorder—Memantine—Alzheimer's disease	5.71e-05	0.000849	CcSEcCtD
Oxycodone—Somnolence—Donepezil—Alzheimer's disease	5.7e-05	0.000848	CcSEcCtD
Oxycodone—Oedema—Rivastigmine—Alzheimer's disease	5.69e-05	0.000847	CcSEcCtD
Oxycodone—Tachycardia—Memantine—Alzheimer's disease	5.68e-05	0.000845	CcSEcCtD
Oxycodone—Diarrhoea—Galantamine—Alzheimer's disease	5.66e-05	0.000842	CcSEcCtD
Oxycodone—Infection—Rivastigmine—Alzheimer's disease	5.66e-05	0.000841	CcSEcCtD
Oxycodone—Skin disorder—Memantine—Alzheimer's disease	5.65e-05	0.000841	CcSEcCtD
Oxycodone—Dyspepsia—Donepezil—Alzheimer's disease	5.64e-05	0.000839	CcSEcCtD
Oxycodone—Hyperhidrosis—Memantine—Alzheimer's disease	5.63e-05	0.000837	CcSEcCtD
Oxycodone—Shock—Rivastigmine—Alzheimer's disease	5.6e-05	0.000833	CcSEcCtD
Oxycodone—Nervous system disorder—Rivastigmine—Alzheimer's disease	5.58e-05	0.00083	CcSEcCtD
Oxycodone—Decreased appetite—Donepezil—Alzheimer's disease	5.57e-05	0.000829	CcSEcCtD
Oxycodone—Tachycardia—Rivastigmine—Alzheimer's disease	5.56e-05	0.000827	CcSEcCtD
Oxycodone—Anorexia—Memantine—Alzheimer's disease	5.55e-05	0.000825	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	5.53e-05	0.000823	CcSEcCtD
Oxycodone—CYP2D6—brain—Alzheimer's disease	5.53e-05	0.00903	CbGeAlD
Oxycodone—Skin disorder—Rivastigmine—Alzheimer's disease	5.53e-05	0.000823	CcSEcCtD
Oxycodone—Fatigue—Donepezil—Alzheimer's disease	5.53e-05	0.000822	CcSEcCtD
Oxycodone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	5.5e-05	0.000819	CcSEcCtD
Oxycodone—Pain—Donepezil—Alzheimer's disease	5.48e-05	0.000815	CcSEcCtD
Oxycodone—Constipation—Donepezil—Alzheimer's disease	5.48e-05	0.000815	CcSEcCtD
Oxycodone—Dizziness—Galantamine—Alzheimer's disease	5.47e-05	0.000814	CcSEcCtD
Oxycodone—Hypotension—Memantine—Alzheimer's disease	5.44e-05	0.000809	CcSEcCtD
Oxycodone—Anorexia—Rivastigmine—Alzheimer's disease	5.43e-05	0.000807	CcSEcCtD
Oxycodone—Hypotension—Rivastigmine—Alzheimer's disease	5.32e-05	0.000791	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	5.3e-05	0.000789	CcSEcCtD
Oxycodone—Feeling abnormal—Donepezil—Alzheimer's disease	5.28e-05	0.000786	CcSEcCtD
Oxycodone—Insomnia—Memantine—Alzheimer's disease	5.26e-05	0.000783	CcSEcCtD
Oxycodone—Vomiting—Galantamine—Alzheimer's disease	5.26e-05	0.000782	CcSEcCtD
Oxycodone—Gastrointestinal pain—Donepezil—Alzheimer's disease	5.24e-05	0.00078	CcSEcCtD
Oxycodone—Paraesthesia—Memantine—Alzheimer's disease	5.23e-05	0.000777	CcSEcCtD
Oxycodone—Rash—Galantamine—Alzheimer's disease	5.22e-05	0.000776	CcSEcCtD
Oxycodone—Dermatitis—Galantamine—Alzheimer's disease	5.21e-05	0.000775	CcSEcCtD
Oxycodone—Dyspnoea—Memantine—Alzheimer's disease	5.19e-05	0.000772	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	5.19e-05	0.000772	CcSEcCtD
Oxycodone—Headache—Galantamine—Alzheimer's disease	5.18e-05	0.000771	CcSEcCtD
Oxycodone—Somnolence—Memantine—Alzheimer's disease	5.17e-05	0.00077	CcSEcCtD
Oxycodone—Insomnia—Rivastigmine—Alzheimer's disease	5.15e-05	0.000766	CcSEcCtD
Oxycodone—Dyspepsia—Memantine—Alzheimer's disease	5.12e-05	0.000762	CcSEcCtD
Oxycodone—Paraesthesia—Rivastigmine—Alzheimer's disease	5.11e-05	0.00076	CcSEcCtD
Oxycodone—Urticaria—Donepezil—Alzheimer's disease	5.09e-05	0.000757	CcSEcCtD
Oxycodone—Dyspnoea—Rivastigmine—Alzheimer's disease	5.08e-05	0.000755	CcSEcCtD
Oxycodone—Body temperature increased—Donepezil—Alzheimer's disease	5.07e-05	0.000754	CcSEcCtD
Oxycodone—Abdominal pain—Donepezil—Alzheimer's disease	5.07e-05	0.000754	CcSEcCtD
Oxycodone—Somnolence—Rivastigmine—Alzheimer's disease	5.06e-05	0.000753	CcSEcCtD
Oxycodone—Decreased appetite—Memantine—Alzheimer's disease	5.06e-05	0.000753	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Memantine—Alzheimer's disease	5.02e-05	0.000747	CcSEcCtD
Oxycodone—Fatigue—Memantine—Alzheimer's disease	5.02e-05	0.000746	CcSEcCtD
Oxycodone—Dyspepsia—Rivastigmine—Alzheimer's disease	5.01e-05	0.000745	CcSEcCtD
Oxycodone—Codeine—CYP2D6—Alzheimer's disease	4.99e-05	0.0272	CrCbGaD
Oxycodone—Pain—Memantine—Alzheimer's disease	4.98e-05	0.00074	CcSEcCtD
Oxycodone—Constipation—Memantine—Alzheimer's disease	4.98e-05	0.00074	CcSEcCtD
Oxycodone—Decreased appetite—Rivastigmine—Alzheimer's disease	4.95e-05	0.000736	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	4.92e-05	0.000731	CcSEcCtD
Oxycodone—Nausea—Galantamine—Alzheimer's disease	4.91e-05	0.000731	CcSEcCtD
Oxycodone—Fatigue—Rivastigmine—Alzheimer's disease	4.91e-05	0.00073	CcSEcCtD
Oxycodone—Pain—Rivastigmine—Alzheimer's disease	4.87e-05	0.000724	CcSEcCtD
Oxycodone—Constipation—Rivastigmine—Alzheimer's disease	4.87e-05	0.000724	CcSEcCtD
Oxycodone—Feeling abnormal—Memantine—Alzheimer's disease	4.8e-05	0.000713	CcSEcCtD
Oxycodone—Gastrointestinal pain—Memantine—Alzheimer's disease	4.76e-05	0.000708	CcSEcCtD
Oxycodone—Hydromorphone—CYP2D6—Alzheimer's disease	4.75e-05	0.0259	CrCbGaD
Oxycodone—Hypersensitivity—Donepezil—Alzheimer's disease	4.72e-05	0.000702	CcSEcCtD
Oxycodone—Feeling abnormal—Rivastigmine—Alzheimer's disease	4.69e-05	0.000698	CcSEcCtD
Oxycodone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	4.66e-05	0.000692	CcSEcCtD
Oxycodone—Urticaria—Memantine—Alzheimer's disease	4.62e-05	0.000688	CcSEcCtD
Oxycodone—Abdominal pain—Memantine—Alzheimer's disease	4.6e-05	0.000684	CcSEcCtD
Oxycodone—Body temperature increased—Memantine—Alzheimer's disease	4.6e-05	0.000684	CcSEcCtD
Oxycodone—Asthenia—Donepezil—Alzheimer's disease	4.6e-05	0.000684	CcSEcCtD
Oxycodone—Pruritus—Donepezil—Alzheimer's disease	4.54e-05	0.000675	CcSEcCtD
Oxycodone—Galantamine—CYP2D6—Alzheimer's disease	4.54e-05	0.0247	CrCbGaD
Oxycodone—Urticaria—Rivastigmine—Alzheimer's disease	4.52e-05	0.000673	CcSEcCtD
Oxycodone—Body temperature increased—Rivastigmine—Alzheimer's disease	4.5e-05	0.000669	CcSEcCtD
Oxycodone—Abdominal pain—Rivastigmine—Alzheimer's disease	4.5e-05	0.000669	CcSEcCtD
Oxycodone—Diarrhoea—Donepezil—Alzheimer's disease	4.39e-05	0.000652	CcSEcCtD
Oxycodone—Hypersensitivity—Memantine—Alzheimer's disease	4.29e-05	0.000638	CcSEcCtD
Oxycodone—Dizziness—Donepezil—Alzheimer's disease	4.24e-05	0.00063	CcSEcCtD
Oxycodone—Hypersensitivity—Rivastigmine—Alzheimer's disease	4.2e-05	0.000624	CcSEcCtD
Oxycodone—Asthenia—Memantine—Alzheimer's disease	4.18e-05	0.000621	CcSEcCtD
Oxycodone—Pruritus—Memantine—Alzheimer's disease	4.12e-05	0.000612	CcSEcCtD
Oxycodone—Asthenia—Rivastigmine—Alzheimer's disease	4.09e-05	0.000608	CcSEcCtD
Oxycodone—Vomiting—Donepezil—Alzheimer's disease	4.08e-05	0.000606	CcSEcCtD
Oxycodone—Rash—Donepezil—Alzheimer's disease	4.04e-05	0.000601	CcSEcCtD
Oxycodone—Dermatitis—Donepezil—Alzheimer's disease	4.04e-05	0.000601	CcSEcCtD
Oxycodone—Pruritus—Rivastigmine—Alzheimer's disease	4.03e-05	0.000599	CcSEcCtD
Oxycodone—Headache—Donepezil—Alzheimer's disease	4.02e-05	0.000597	CcSEcCtD
Oxycodone—Diarrhoea—Memantine—Alzheimer's disease	3.98e-05	0.000592	CcSEcCtD
Oxycodone—Diarrhoea—Rivastigmine—Alzheimer's disease	3.9e-05	0.000579	CcSEcCtD
Oxycodone—Dizziness—Memantine—Alzheimer's disease	3.85e-05	0.000572	CcSEcCtD
Oxycodone—Nausea—Donepezil—Alzheimer's disease	3.81e-05	0.000566	CcSEcCtD
Oxycodone—Dizziness—Rivastigmine—Alzheimer's disease	3.77e-05	0.00056	CcSEcCtD
Oxycodone—Vomiting—Memantine—Alzheimer's disease	3.7e-05	0.00055	CcSEcCtD
Oxycodone—Rash—Memantine—Alzheimer's disease	3.67e-05	0.000546	CcSEcCtD
Oxycodone—Dermatitis—Memantine—Alzheimer's disease	3.67e-05	0.000545	CcSEcCtD
Oxycodone—Headache—Memantine—Alzheimer's disease	3.65e-05	0.000542	CcSEcCtD
Oxycodone—Vomiting—Rivastigmine—Alzheimer's disease	3.62e-05	0.000538	CcSEcCtD
Oxycodone—Rash—Rivastigmine—Alzheimer's disease	3.59e-05	0.000534	CcSEcCtD
Oxycodone—Dermatitis—Rivastigmine—Alzheimer's disease	3.59e-05	0.000533	CcSEcCtD
Oxycodone—Headache—Rivastigmine—Alzheimer's disease	3.57e-05	0.000531	CcSEcCtD
Oxycodone—Nausea—Memantine—Alzheimer's disease	3.46e-05	0.000514	CcSEcCtD
Oxycodone—Nausea—Rivastigmine—Alzheimer's disease	3.38e-05	0.000503	CcSEcCtD
Oxycodone—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	4.79e-06	0.000516	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	4.77e-06	0.000514	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR2A—Alzheimer's disease	4.76e-06	0.000512	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—F2—Alzheimer's disease	4.75e-06	0.000512	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	4.69e-06	0.000505	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PLCB1—Alzheimer's disease	4.67e-06	0.000503	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NPS—Alzheimer's disease	4.67e-06	0.000503	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PPP3CA—Alzheimer's disease	4.65e-06	0.000501	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	4.61e-06	0.000497	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—F2—Alzheimer's disease	4.59e-06	0.000495	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTK2B—Alzheimer's disease	4.58e-06	0.000493	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	4.52e-06	0.000487	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.52e-06	0.000487	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ND1—Alzheimer's disease	4.46e-06	0.00048	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GAB2—Alzheimer's disease	4.46e-06	0.00048	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SST—Alzheimer's disease	4.46e-06	0.00048	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	4.46e-06	0.00048	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	4.44e-06	0.000478	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	4.43e-06	0.000477	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	4.42e-06	0.000476	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	4.36e-06	0.00047	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APP—Alzheimer's disease	4.34e-06	0.000468	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	4.33e-06	0.000467	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ACHE—Alzheimer's disease	4.33e-06	0.000467	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	4.33e-06	0.000467	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	4.32e-06	0.000465	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	4.29e-06	0.000462	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	4.28e-06	0.000461	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	4.26e-06	0.000459	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	4.24e-06	0.000457	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	4.17e-06	0.000449	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	4.16e-06	0.000449	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	4.11e-06	0.000443	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	4.1e-06	0.000441	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	4.06e-06	0.000437	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ENO1—Alzheimer's disease	4.06e-06	0.000437	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TPI1—Alzheimer's disease	4.04e-06	0.000435	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CHAT—Alzheimer's disease	4.04e-06	0.000435	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	4.03e-06	0.000434	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	4.02e-06	0.000433	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	3.98e-06	0.000429	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	3.95e-06	0.000425	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	3.93e-06	0.000423	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	3.88e-06	0.000418	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MAOB—Alzheimer's disease	3.87e-06	0.000417	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	3.87e-06	0.000417	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.84e-06	0.000414	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	3.83e-06	0.000413	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	3.82e-06	0.000412	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	3.8e-06	0.000409	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—BCHE—Alzheimer's disease	3.77e-06	0.000407	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	3.77e-06	0.000406	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SST—Alzheimer's disease	3.77e-06	0.000406	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	3.77e-06	0.000406	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	3.75e-06	0.000404	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	3.73e-06	0.000402	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	3.73e-06	0.000402	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	3.73e-06	0.000402	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	3.72e-06	0.0004	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	3.71e-06	0.000399	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APP—Alzheimer's disease	3.67e-06	0.000395	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.61e-06	0.000389	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—A2M—Alzheimer's disease	3.6e-06	0.000388	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	3.56e-06	0.000384	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	3.55e-06	0.000383	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	3.53e-06	0.00038	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	3.52e-06	0.00038	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	3.52e-06	0.000379	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	3.46e-06	0.000373	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	3.46e-06	0.000372	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	3.45e-06	0.000372	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.43e-06	0.000369	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	3.37e-06	0.000363	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	3.36e-06	0.000362	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	3.27e-06	0.000353	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.27e-06	0.000352	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	3.25e-06	0.00035	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	3.23e-06	0.000348	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	3.21e-06	0.000346	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	3.2e-06	0.000345	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	3.16e-06	0.00034	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	3.14e-06	0.000338	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.13e-06	0.000338	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ACHE—Alzheimer's disease	3.13e-06	0.000337	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	3.12e-06	0.000336	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	3.1e-06	0.000334	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	3.09e-06	0.000333	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	3.03e-06	0.000326	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.02e-06	0.000325	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	2.99e-06	0.000322	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	2.98e-06	0.000321	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	2.98e-06	0.000321	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	2.98e-06	0.000321	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	2.98e-06	0.000321	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	2.96e-06	0.000319	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	2.95e-06	0.000318	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	2.95e-06	0.000318	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ENO1—Alzheimer's disease	2.93e-06	0.000316	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	2.93e-06	0.000316	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.91e-06	0.000314	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	2.88e-06	0.00031	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CHAT—Alzheimer's disease	2.87e-06	0.000309	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TPI1—Alzheimer's disease	2.87e-06	0.000309	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	2.87e-06	0.000309	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	2.84e-06	0.000306	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	2.84e-06	0.000306	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	2.81e-06	0.000303	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—F2—Alzheimer's disease	2.81e-06	0.000303	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MAOB—Alzheimer's disease	2.75e-06	0.000297	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.75e-06	0.000296	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	2.75e-06	0.000296	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—BCHE—Alzheimer's disease	2.73e-06	0.000294	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—LPL—Alzheimer's disease	2.71e-06	0.000292	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	2.65e-06	0.000286	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	2.63e-06	0.000284	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	2.62e-06	0.000282	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	2.61e-06	0.000281	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	2.61e-06	0.000281	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	2.61e-06	0.000281	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	2.59e-06	0.000279	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	2.58e-06	0.000278	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	2.57e-06	0.000277	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	2.56e-06	0.000276	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—A2M—Alzheimer's disease	2.56e-06	0.000276	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	2.56e-06	0.000276	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—INS—Alzheimer's disease	2.54e-06	0.000274	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	2.5e-06	0.00027	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	2.5e-06	0.000269	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	2.49e-06	0.000269	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	2.49e-06	0.000269	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—F2—Alzheimer's disease	2.46e-06	0.000265	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	2.46e-06	0.000265	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	2.44e-06	0.000263	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	2.43e-06	0.000261	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.41e-06	0.00026	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	2.37e-06	0.000256	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CALM1—Alzheimer's disease	2.28e-06	0.000245	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—Alzheimer's disease	2.27e-06	0.000245	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	2.26e-06	0.000244	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CAV1—Alzheimer's disease	2.25e-06	0.000242	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	2.24e-06	0.000242	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	2.23e-06	0.00024	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—INS—Alzheimer's disease	2.23e-06	0.00024	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ACHE—Alzheimer's disease	2.23e-06	0.00024	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	2.22e-06	0.000239	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	2.21e-06	0.000238	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	2.21e-06	0.000238	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	2.2e-06	0.000237	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	2.2e-06	0.000237	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	2.19e-06	0.000236	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	2.16e-06	0.000233	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.15e-06	0.000232	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.14e-06	0.000231	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.11e-06	0.000227	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	2.09e-06	0.000225	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO1—Alzheimer's disease	2.09e-06	0.000225	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—F2—Alzheimer's disease	2.08e-06	0.000224	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.04e-06	0.000219	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.98e-06	0.000213	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.96e-06	0.000211	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	1.96e-06	0.000211	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.94e-06	0.000209	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—INS—Alzheimer's disease	1.94e-06	0.000209	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.91e-06	0.000206	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.91e-06	0.000206	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	1.9e-06	0.000204	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.89e-06	0.000204	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—INS—Alzheimer's disease	1.89e-06	0.000203	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.88e-06	0.000203	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.88e-06	0.000202	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.88e-06	0.000202	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.86e-06	0.0002	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	1.83e-06	0.000197	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.82e-06	0.000197	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.8e-06	0.000194	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	1.77e-06	0.000191	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.76e-06	0.00019	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.74e-06	0.000188	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.74e-06	0.000187	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.73e-06	0.000187	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.7e-06	0.000183	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.68e-06	0.000181	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.67e-06	0.00018	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	1.66e-06	0.000179	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.65e-06	0.000178	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	1.65e-06	0.000178	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.65e-06	0.000177	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.64e-06	0.000177	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.63e-06	0.000175	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.61e-06	0.000173	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.56e-06	0.000168	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	1.53e-06	0.000165	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.53e-06	0.000164	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	1.52e-06	0.000164	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	1.52e-06	0.000164	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.48e-06	0.000159	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.46e-06	0.000157	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.44e-06	0.000155	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.43e-06	0.000154	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.42e-06	0.000153	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	1.41e-06	0.000152	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.4e-06	0.000151	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—INS—Alzheimer's disease	1.4e-06	0.000151	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.39e-06	0.00015	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.39e-06	0.00015	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.36e-06	0.000147	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.36e-06	0.000147	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.34e-06	0.000144	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.29e-06	0.000139	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.29e-06	0.000139	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.29e-06	0.000139	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.27e-06	0.000137	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.25e-06	0.000135	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.23e-06	0.000132	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	1.21e-06	0.000131	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.2e-06	0.000129	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.19e-06	0.000128	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.17e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.17e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.16e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.16e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.12e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	1.11e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.09e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	1.07e-06	0.000115	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.03e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.02e-06	0.00011	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—INS—Alzheimer's disease	9.97e-07	0.000107	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	9.95e-07	0.000107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	9.75e-07	0.000105	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPL—Alzheimer's disease	9.1e-07	9.81e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	9e-07	9.7e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	8.99e-07	9.69e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	8.74e-07	9.42e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	8.24e-07	8.88e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	8.2e-07	8.83e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	8e-07	8.62e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—Alzheimer's disease	7.82e-07	8.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.66e-07	8.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.63e-07	8.22e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	7.6e-07	8.19e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.56e-07	8.14e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.65e-07	7.16e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—INS—Alzheimer's disease	6.52e-07	7.02e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.72e-07	6.16e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	5.65e-07	6.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.23e-07	5.63e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	4.02e-07	4.33e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.63e-07	2.83e-05	CbGpPWpGaD
